Cargando…
Novel Drug Targets for Central Apneas in Heart Failure: On the Road
Autores principales: | Borrelli, Chiara, Gentile, Francesco, Sciarrone, Paolo, Spiesshoefer, Jens, Navari, Alessandro, Passino, Claudio, Emdin, Michele, Giannoni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480255/ https://www.ncbi.nlm.nih.gov/pubmed/34086532 http://dx.doi.org/10.1164/rccm.202104-0846LE |
Ejemplares similares
-
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure
por: Gentile, Francesco, et al.
Publicado: (2022) -
Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019) -
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure
por: Spiesshoefer, Jens, et al.
Publicado: (2020) -
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing
por: Spiesshoefer, Jens, et al.
Publicado: (2022) -
Contribution of the Lung to the Genesis of Cheyne‐Stokes Respiration in Heart Failure: Plant Gain Beyond Chemoreflex Gain and Circulation Time
por: Giannoni, Alberto, et al.
Publicado: (2019)